On the ability of caerulein to increase propulsive activity in the isolated small and large intestine.
D000818:Animals; D001001:Anura; D001285:Atropine / Q000037:antagonists & inhibitors; D002766:Cholecystokinin / Q000494:pharmacology; D003080:Cold Temperature; D003106:Colon; D005260:Female; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000037:antagonists & inhibitors; D007082:Ileum; D066298:In Vitro Techniques; D007420:Intestine, Large / Q000502:physiology*; D007421:Intestine, Small / Q000502:physiology*; D008297:Male; D008638:Mesenteric Arteries; D010388:Pelvis / Q000294:innervation; D010455:Peptides / Q000494:pharmacology*; D010477:Perfusion; D010879:Piperazines / Q000494:pharmacology; D012018:Reflex / Q000187:drug effects; D013268:Stimulation, Chemical; D013779:Tetrodotoxin / Q000494:pharmacology
D005765:Gastrointestinal Agents; D006584:Hexamethonium Compounds; D010455:Peptides; D010879:Piperazines; D013779:Tetrodotoxin; D001285:Atropine; D002766:Cholecystokinin